ROCKWELL MEDICAL, INC. 8-K

What Happened
Rockwell Medical, Inc. (RMTI) announced on its Form 8-K that on July 16, 2026 it received written notice from the Nasdaq Listing Qualifications Staff confirming the company has regained compliance with the minimum $1.00 per share bid price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq indicated the compliance matter is closed.

Key Details

• Nasdaq compliance letter dated July 16, 2026 confirmed restoration of the $1.00 minimum bid price requirement.
• Nasdaq Listing Rule referenced: 5550(a)(2) (minimum bid price rule).
• Company furnished a press release dated July 20, 2026 in connection with the announcement.

Why It Matters
Regaining compliance means Rockwell Medical remains listed on The Nasdaq Capital Market, avoiding potential delisting consequences tied to the bid price deficiency. For shareholders, this reduces short-term listing risk and preserves the stock’s liquidity and access to Nasdaq’s investor base.